about
Management of bleeding and coagulopathy following major trauma: an updated European guideline.Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disordersAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic reviewA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopeniaComparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopeniaUse of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopeniaComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationProphylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAntifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disordersAnti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disordersUse of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopeniaHemostasis in liver transplantation: Pathophysiology, monitoring, and treatmentTransfusion medicine problems and solutions for the pediatric hematologist/oncologistEvidence and triggers for the transfusion of blood and blood productsIndications for platelet transfusion in patients with thrombocytopeniaThe European guideline on management of major bleeding and coagulopathy following trauma: fourth editionWhere did platelets go in 2012? A survey of platelet transfusion practice in the North of EnglandWhy has demand for platelet components increased? A reviewEvaluation of platelet transfusion triggers in a tertiary-care hospitalFrequently asked questions on seven rare adverse events following immunization.Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials.Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.Compliance with prophylactic platelet transfusion trigger in haematological patients.Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation.Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials.The practice of platelet transfusion in the intensive care unit.Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.Effects of high-yield thrombocytapheresis on the quality of platelet products.Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.Performance of automated platelet quantification using different analysers in comparison with an immunological reference method in thrombocytopenic patientsCaring for the terminally ill patient with hematologic malignancies.Coronary artery bypass grafting in idiopathic thrombocytopenia: use of thromboelastometry without platelet transfusion
P2860
Q21092902-F5F76C99-4679-4A23-BD27-507D137C47C2Q24186028-789C3DF5-F9DA-40C7-881A-A20E213D0FAAQ24186703-01F57026-FA50-4BEB-BFA6-8A8962F36056Q24186913-17406E73-B899-43A3-9236-15F2838C8A77Q24187258-A4C12E42-7958-4209-BFA0-438071A555CCQ24187460-C2DD39F4-4C2A-4F98-A66D-497BA1452EB7Q24187543-DA960F31-B796-42D1-B6CA-0A97CDB49992Q24187751-A1837FC8-4CE4-43D4-B142-43A966A098DDQ24197779-CBD213CE-2BEA-4C5C-8C0D-06743DB3B2D6Q24198288-B3543EB8-CF0C-45A4-BD0E-A18E3A4E4CE2Q24198774-ACF66EF5-2009-4402-8AC2-7009A0AEC340Q24198795-47871393-8B77-4EE8-A384-1ACD6DC737BBQ24201018-78F1D3D5-AD5E-4787-81AC-2A3511033D4CQ24201514-8B4BB003-A691-45E3-82B6-1ACC067441FBQ26471928-DFD87AC3-E20D-4D37-9682-B31CDEA5D23AQ26773233-0B8B0DE7-4D21-4CDC-9A23-64357F4A2BAAQ26851995-AAC29E32-E5DE-47D6-8C95-AD69BA87B22DQ27008573-6246DAB1-803D-4770-8779-44C2366A18F6Q27023734-E923F5EB-7710-4DAD-BD86-711DED46860FQ27339343-38BF10DE-C355-45EA-B9A9-1C279325B431Q28242680-E7EA50D0-686E-4F50-A680-3EFEE808872DQ28249969-329DEABD-A86F-4EC8-893E-C440B5FB18FCQ28288397-B14F9912-655E-4D0F-94ED-6C280F23894AQ30234430-520AA977-A59B-4A63-B9AD-26882CDC8829Q30248355-4A12BBEB-F71C-49CA-8AF1-6C3F67C20730Q30248755-D8DBF8F4-0415-42C6-9DAA-AEB8AACA19C9Q30635705-F2E31265-8710-4E8F-8549-3FA1AF2379AEQ33365020-F510253E-88F0-43DE-89DE-EC1B340767EAQ33369562-AD63F195-26B9-4821-93DA-43B4670119FBQ33370895-60126A63-AE39-48DE-A4D8-4989B725A26EQ33371442-C6EDC4DC-A601-47DE-A670-67C8CA067AA3Q33372452-04640386-2177-4177-8192-5C2468FBBE2CQ33374336-98155350-E31F-4C93-91CC-5B8F07F4C877Q33375078-4E8234D2-B860-401C-A44F-04911E51A965Q33375476-16DC143E-D49D-4D86-A620-BECC11130116Q33377710-F2FD6CB5-99E7-4646-9330-E8A19BACBEF4Q33382275-6ABDDB04-D81E-41E7-8F50-2879925B3C4BQ33383731-42D4122A-1F81-40C4-AD9C-D9C7AD28D4F3Q33384013-4E8A7D14-B83D-4874-9482-87C7159966E7Q33390130-098E93A1-6896-43D9-B9FA-506FA0BFD4F5
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Guidelines for the use of platelet transfusions.
@ast
Guidelines for the use of platelet transfusions.
@en
type
label
Guidelines for the use of platelet transfusions.
@ast
Guidelines for the use of platelet transfusions.
@en
prefLabel
Guidelines for the use of platelet transfusions.
@ast
Guidelines for the use of platelet transfusions.
@en
P2860
P1476
Guidelines for the use of platelet transfusions.
@en
P2093
British Committee for Standards in Haematology, Blood Transfusion Task Force
P2860
P356
10.1046/J.1365-2141.2003.04468.X
P407
P577
2003-07-01T00:00:00Z